N-acetylcysteine effect on the luminol-dependent chemiluminescence pattern of reactive oxygen species generation by human polymorphonuclear leukocytes

Pulmonary Pharmacology and Therapeutics

Volumn 15, Issue 4, 2002, Pages 385-392

  Stolarek, Robert ^a   Białasiewicz, Piotr ^a   Nowak, Dariusz ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Chemiluminescence; Intracellular thiols; N acetylcysteine; Polymorphonuclear leukocytes; Reactive oxygen species; Respiratory burst

Indexed keywords

ACC; ACETYLCYSTEINE; BUFFER; FORMYLMETHIONYLLEUCYLPHENYLALANINE; HYDROGEN PEROXIDE; LUMINOL; PHORBOL 13 ACETATE 12 MYRISTATE; REACTIVE OXYGEN METABOLITE; THIOL; TOSYLCHLORAMIDE SODIUM;

ADULT; ARTICLE; BLOOD CHEMISTRY; CELL ACTIVATION; CELL LEVEL; CELL STIMULATION; CELL SUSPENSION; CHEMOLUMINESCENCE; CONCENTRATION RESPONSE; DRUG EFFECT; DRUG OXIDATION; DRUG RESPONSE; FEMALE; HUMAN; HUMAN CELL; INCUBATION TIME; MALE; NEUTROPHIL; NORMAL HUMAN; PRIORITY JOURNAL; RESPIRATORY BURST;

EID: 0036385848     PISSN: 10945539     EISSN: None     Source Type: Journal    
DOI: 10.1006/pupt.2002.0369     Document Type: Article

References (32)

1. Bridgeman M M E, Mardsen M, Selby C, Morrison D, MacNee W. Effect of N-acetyl cysteine on the concentrations of thiols in plasma, bronchoalveolar lavage fluid, and lung tissue. Thorax 1994; 49: 670-675.
2. Riise G C, Williams A, Kjellstrom C, Schersten H, Andersson B A, Kelly F J. Bronchiolitis obliterans syndrome in lung transplant recipients is associated with increased neutrophils activity and decreased antioxidant status in the lung. Eur Respir J 1998; 12: 82-88.
3. Behr J, Maier K, Degenkolb B, Krombach F, Vogelmeier A. Antioxidant and clinical effects of high-dose N-acetylcysteine in fibrosing alveolitis: Adjunctive therapy to maintenance immunosuppression. Am J Respir Crit Care Med 1997; 156: 1897-1901.
4. Kasielski M, Nowak D. Long-term administration of N-acetylcysteine decreases hydrogen peroxide exhalation in subjects with chronic obstructive pulmonary disease. Respir Med 2001; 95: 448-456.
5. Stolarek R, Kula P, Kurmanowska Z, Nowak D. Effect of various agonists on nitric oxide generation by human polymorphonuclear leukocytes. Int J Clin Lab Res 1998; 28: 104-109.
6. Gillissen A, Nowak D. Characterization of N-acetylcysteine and ambroxol in anti-oxidant therapy. Respir Med 1998; 92: 609-623.
7. Phelps D T, Deneke S M, Daley D L, Fanburg B L. Elevation of glutathione levels in bovine pulmonary artery endothelial cells by N-acetylcysteine. Am J Respir Cell Mol Biol 1992; 7: 293-299.
8. Vecchiarelli A, Dottorini M, Pietrella D, Cociani C, Eslami A, Todisco T, Bistoni F. Macrophage activation by N-acetylcysteine in COPD patients. Chest 1994; 105: 806-811.
9. Oddera S, Silvestri M, Sacco O, Eftimiadi C, Rossi G A. N-acetylcysteine enhances in vitro the intracellular killing of Staphylococcus aureus by human alveolar macrophages and blood polymorphonuclear leukocytes and partially protects phagocytes from self-killing. J Lab Clin Med 1994; 124: 293-301.
10. Gressier B, Cabanis A, Lebegue S, Brunet C, Dine T, Luyckx M, Cazin M, Cazin J C. Decrease of hypochlorous acid and hydroxyl radical generated by stimulated human neutrophils: comparison in vitro of some thiol-containing drugs. Methods Find Exp Clin Pharmacol 1994; 16: 9-13.
11. Gressier B, Cabanis A, Lebegue S, Brunet C, Dine T, Luyckx M, Cazin M, Cazin J C. Comparison of in vitro effects of two thiol-containing drugs on human neutrophils hydrogen peroxide production. Methods Find Exp Clin Pharmacol 1993; 15: 101-105.
12. Bernard G R, Lucht W D, Niedermeyer M E, Snapper J R, Ogletree M L, Brigham K L. Effect of N-acetylcysteine on the pulmonary response to endotoxin in the awake sheep and upon in vitro granulocyte function. J Clin Invest 1984; 73: 1772-1784.
13. Misso N L A, Peacock C D, Watkins D N, Thompson P J. Nitrite generation and antioxidant effects during neutrophil apoptosis. Free Radical Biol Med 2000; 28: 934-943.
14. Van-Dervort A L, Yan L, Madara P J, Cobb J P, Wesley R A, Corriveau C C, Tropea M M, Danner R L. Nitric oxide regulates endotoxin-induced TNF-alpha production by human neutrophils. J Immunol 1994; 152: 4102-4109.
15. Corriveau C C, Madara P J, Van Dervort A L, Tropea M M, Wesley R A, Danner R L. Effects of nitric oxide on chemotaxis and endotoxin-induced interleukin-8 production in human neutrophils. J Infect Disease 1998; 177: 116-126.
16. Kalipada P, Sheikh F G, Namboodiri A M S, Singh I. N-acetyl cysteine inhibits induction of NO production by endotoxin or cytokine stimulated rat peritoneal macrophages, C6 gial cells and astrocytes. Free Rad Biol Med 1998; 24: 39-48.
17. Boyum A. Isolation of mononuclear cells and granulocytes from human blood. Scand J Clin Lab Invest 1968; 97 [Suppl]: 77.
18. Kuo C H, Hook J B. Depletion of renal glutathione content and nephrotoxicity of cephaloridine in rabbits, rats, and mice. Toxicol and Appl Pharmacol 1982, 63: 292-302.
19. Kukovetz E M, Bratschitsch G, Hofer H P, Egger G, Schaur R J. Influence of age on the release of reactive oxygen species by phagocytes as measured by a whole blood chemiluminescence assay. Free Radical Biol Med 1997; 22: 433-438.
20. Dent G, Rabe K F, Magnussen H. Augmentation of human neutrophil and alveolar macrophage LTB4 production by N-acetylcysteine: role of hydrogen peroxide. Br J Pharmacol 1997; 122: 758-764.
21. Kharazmi A, Nielsen H, Schiotz P O. N-acetylcysteine inhibits human neutrophil and monocyte chemotaxis and oxidative metabolism. Int J Immunopharmacol 1988; 10: 39-46.
22. Mahlis E, Christophidis N. Modulation of the iodination reaction in normal human neutrophils and in whole blood by penicilamine, congeners and intracellular enzyme catalase and superoxide dismutase. Clin Exp Rheumatol 1989; 7: 365-371.
23. Paulsen O, Forsgren A. Effects of N-acetylcysteine on human polymorphonuclear leukocytes. Acta Pathol Microbiol Scand 1989; 97: 115-119.
24. Aruoma O I, Halliwell B, Hoey B M. The antioxidant action of N-acetylcysteine: its reaction with hydrogen peroxide, hydroxyl radical, superoxide and hypochlorous acid. Free Radic Biol Med 1989; 6: 593-597.
25. Gillissen A, Jaworska M, Orth M, Coffiner M, Maes P, App E M, Cantin A M, Schultze-Werninghaus G. Nacystelyn and N-acetylcysteine augment cellular antioxidant defense in two distinctive ways. Respir Med 1997; 91: 159-168.
26. Nowak D. Hydrogen peroxide release from human polymorphonuclear leukocytes measured with horseradish peroxidase and o-dianisidine. Effect of various stimulators and cytochalasin B. Biomed Biochim Acta 1990; 49: 353-362.
27. Homan-Muller J W T, Weening R S, Roos D. Production of hydrogen peroxide by phagocytizing human granulocytes. J Lab Clin Med 1975; 85: 198-207.
28. Jandl R C, Andre-Schwartz J, Borges-DuBois L, Kipnes R S, McMurrich B J, Babior B M. Termination of the respiratory burst in human neutrophils. J Clin Invest 1978; 61: 1176-1185.
29. Jaworska M. Experimental and clinical investigations on antioxidant properties of N-acetylcysteine and N-acystelyn. Doctoral thesis. Promoted by: Nowak D. Medical University of Lodz, Lodz 1996.
30. Borgstrom L, Kagedal B, Paulsen O. Pharmacocinetics of N-acetylcysteine in man Eur J Clin Pharmacol 1986; 31: 217-222.
31. Paulsen O, Borgstrom L, Kagedal B, Walder M. No effect of oral N-acetylcysteine on the bioavailability of ertyhromycin and bacampicillin. Eur Respir J 1988; 1: 171-175.
32. Fluimucil® N-acetylcysteine profile. Italy: Zambon Group Milano, 1998.